OBJECTIVES: to analyze the publications on methodology and normative regulations of pharmacoeconomic studies, including materials providing results of conducted researches in Russia or translated international publications, as well as to analysis the dynamics of publications and identify the structure of methodological approaches in Russia. METHODS: the screening of publications from the data of the Central Medical Scientific Library of the First MSMU was conducted based on the key words - “pharmacoeconomic*” and “pharmacoeconomical*” with corresponding endings. The time horizon of the study was 6 years (from 2007 - 2012). RESULTS: By the beginning of 2013, 280 literature sources were found and analyzed in the timeline from 2007 to 2013. It was found that the most common type of publications for the reporting period have been the inaugural dissertations showing the researches results - they are accounted for about 47% of all studies, followed by further research reports, accounted for 44%, methodical publications - 5%, dissertations devoted to the methodology of the pharmacoeconomics- 3%, regulatory guidance documents and translations of foreign studies -  1%. The most common structure of published researches was monocenter  (56%), with a retrospective time-restricted directivity (74%). Russian authors use the methodology of the "cost-effectiveness» analyzing in their works the most frequently (48%). 64% of Russian researchers take into account only direct costs, 32% of researchers analyze their studies based on indirect costs. CONCLUSIONS: Based on our review of the published works from 2007 to 2012, we can make a conclusion on the formation and development of high-grade pharmacoeconomics as an independent research area in the Russian Federation.